Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain. | Neurobiol Pain | 2025 | 39720155 | PubTator, text mining | PubMed |
| Immune-related genes for the prediction of response to imatinib therapy in chronic myeloid leukemia. | Carcinogenesis | 2025 | 39714081 | PubTator, text mining | PubMed |
| Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice. | Clin Genet | 2025 | 39707869 | PubTator, text mining | PubMed |
| Human cold pain: a randomized crossover trial. | Pain | 2025 | 39693244 | PubTator, text mining | PubMed |
| Analysis of candidate variants in a Chinese family with monozygotic twins with keratoconus: a case report. | Ophthalmic Genet | 2025 | 39544142 | PubTator, text mining | PubMed |
| Genetic associations of neuropathic pain and sensory profile in a deeply phenotyped neuropathy cohort. | Pain | 2025 | 39471050 | PubTator, text mining | PubMed |
| ML-based Models as a Strategy to Discover Novel Antiepileptic Drugs Targeting Sodium Receptor Channel. | Curr Top Med Chem | 2025 | 39440735 | PubTator, text mining | PubMed |
| The Evolving Landscape of Small Fiber Neuropathy. | Semin Neurol | 2025 | 39433284 | PubTator, text mining | PubMed |
| Small molecule targeting Na V 1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model. | Pain | 2025 | 39106443 | PubTator, text mining | PubMed |
| Familial Episodic Pain Syndrome: A Japanese Family Harboring the Novel Variant c.2431C>T (p.Leu811Phe) in SCN11A. | Biochem Genet | 2025 | 39058404 | PubTator, text mining | PubMed |
| Effects of plant extracts and derivatives on cardiac K+, Nav, and Cav channels: a review. | Nat Prod Res | 2025 | 38586947 | PubTator, text mining | PubMed |
| Candidate SNP markers of changes in the expression levels of the human SCN9A gene as a hub gene for pain generation, perception, response and anesthesia. | Vavilovskii Zhurnal Genet Selektsii | 2024 | 39944808 | PubTator, text mining | PubMed |
| Phenotypic drug resistance and genetic mutations linked to resistance among extrapulmonary tuberculosis patients in Ethiopia: Insights from Whole Genome Sequencing. | Res Sq | 2024 | 39764135 | PubTator, text mining | PubMed |
| Paroxysmal extreme pain disorder associated with a mutation in SCN9A gene - Case report and own experiences. | Front Neurol | 2024 | 39711786 | PubTator, text mining | PubMed |
| Molecular genetics in adult-onset Still's disease: next-generation sequencing in 24 patients and literature review. | Front Immunol | 2024 | 39611152 | PubTator, text mining | PubMed |
| Sodium channels Nav1.7, Nav1.8 and pain; two distinct mechanisms for Nav1.7 null analgesia. | Neurobiol Pain | 2024 | 39559752 | PubTator, text mining | PubMed |
| [Genetic analysis of a child with Congenital insensitivity to pain due to compound heterozygous variants of SCN9A gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39528285 | PubTator, text mining | PubMed |
| Small Fiber Neuropathy in Burning Mouth Syndrome: A Systematic Review. | Int J Mol Sci | 2024 | 39518993 | PubTator, text mining | PubMed |
| Previously defined variants of uncertain significance may play an important role in epilepsy and interactions between certain variants may become pathogenic. | Epilepsia Open | 2024 | 39509559 | PubTator, text mining | PubMed |
| Molecular determinants of resurgent sodium currents mediated by Navβ4 peptide and A-type FHFs. | Front Mol Neurosci | 2024 | 39416265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=11